ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Charlotte, NC, USA:

A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: Normal saline
Drug: VYD222

Phase 3

Invivyd

Salisbury, North Carolina, United States and 17 other locations

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Monroe, North Carolina, United States of America and 217 other locations

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

Phase 2

Enanta Pharmaceuticals
Enanta Pharmaceuticals

Shelby, North Carolina, United States and 20 other locations

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...

Active, not recruiting
COVID-19
Drug: PBI-0451 (Pomotrelvir)
Drug: Placebo

Phase 2

Pardes Biosciences

Denver, North Carolina, United States and 53 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Charlotte, North Carolina, United States and 214 other locations

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Enrolling
COVID-19
Influenza
Biological: Influenza and COVID-19 Combination B
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

Monroe, North Carolina, United States of America and 158 other locations

The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need t...

Active, not recruiting
COVID-19
SARS CoV 2 Infection
Drug: Bemnifosbuvir (BEM)
Drug: Placebo

Phase 3

Atea Pharmaceuticals
Atea Pharmaceuticals

Rock Hill, South Carolina, United States and 263 other locations

This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...

Active, not recruiting
COVID-19
Biological: NVX-CoV2601 (5μg)
Biological: NVX-CoV2601 (35μg)

Phase 2, Phase 3

Novavax
Novavax

Gaffney, South Carolina, United States and 49 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 2, Phase 3

BioNTech
BioNTech

Charlotte, North Carolina, United States and 114 other locations

The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19...

Active, not recruiting
SARS-CoV-2 Infection
Drug: S-217622
Drug: Placebo

Phase 3

Shionogi
Shionogi

Charlotte, North Carolina, United States and 188 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems